The use of rituximab in the treatment of malignant and nonmalignant plasma cell disorders

被引：81

作者：

Treon, SP

Anderson, KC

机构：

[1] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA

来源：

SEMINARS IN ONCOLOGY | 2000年 / 27卷 / 06期

关键词：

D O I：

10.1053/sonc.2000.20425

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：79 / 85

页数：7

共 49 条

[41] A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase polymerase chain reaction [J].

Szczepek, AJ ;

Seeberger, K ;

Wizniak, J ;

Mant, MJ ;

Belch, AR ;

Pilarski, LM .

BLOOD, 1998, 92 (08) :2844-2855

[42] CELLULAR-ORIGIN AND EXTENT OF CLONAL INVOLVEMENT IN MULTIPLE-MYELOMA - GENETIC AND PHENOTYPIC STUDIES [J].

TAKISHITA, M ;

KOSAKA, M ;

GOTO, T ;

SAITO, S .

BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (04) :735-742

[43]

TERSTAPPEN LWMM, 1990, BLOOD, V76, P1739

[44] Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma [J].

Treon, SP ;

Maimonis, P ;

Bua, D ;

Young, G ;

Raje, N ;

Mollick, J ;

Chauhan, D ;

Tai, YT ;

Hideshima, T ;

Shima, Y ;

Hilgers, J ;

von Mensdorff-Pouilly, S ;

Belch, AR ;

Pilarski, LM ;

Anderson, KC .

BLOOD, 2000, 96 (09) :3147-3153

[45] Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone [J].

Treon, SP ;

Mollick, JA ;

Urashima, M ;

Teoh, G ;

Chauhan, D ;

Ogata, A ;

Raje, N ;

Hilgers, JHM ;

Nadler, L ;

Belch, AR ;

Pilarski, LM ;

Anderson, KC .

BLOOD, 1999, 93 (04) :1287-1298

[46]

Treon SP, 1999, BLOOD, V94, p312A

[47]

Treon SP, 1999, SEMIN ONCOL, V26, P97

[48]

TREON SP, 2000, P AN M AM SOC CLIN, V19, pA6

[49]

Weber DM, 1999, BLOOD, V94, p125A

← 1 2 3 4 5 →